Joe Springer's  Instablog

Joe Springer
  • on Retirement
Send Message
It is very hard or impossible to time the broad market consistently — there are no famous investors that got rich by consistently knowing what the broad market would do next. This only makes sense, as there are just too many variables in the broad market. But there are many famous investors who... More
My company:
My blog:
The Wall Street Exclusive
  • MannKind Technicals - Cup And Handle Or Reverse Head And Shoulders 6 comments
    Feb 27, 2013 2:20 PM | about stocks: MNKD

    For those that like technical analysis - have a look at MannKind (NASDAQ:MNKD):

    (click to enlarge)

    I see a cup and handle and the wedge of higher lows since November and in February. This looks like it is basing - preparing to move higher.

    I could be talked into seeing a pair of reverse head and shoulders patterns completing, one starting in September, one in January.

    I'm on record about MannKind being my favorite speculation in the market on fundamentals, and the chart sure looks good.

    Just sayin.

    Disclosure: I am long MNKD.

    Stocks: MNKD
Back To Joe Springer's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (6)
Track new comments
  • vireoman
    , contributor
    Comments (1266) | Send Message
    I'm not a believer in technicals, but I have become a believer in MNKD (well, at least in the one with consecutive n's; I'm still agnostic on the other). Bought shares twice in the past week, and am now at my maximum-allowable for a speculative biotech. (I learned a hard lesson from DNDN).
    27 Feb 2013, 04:36 PM Reply Like
  • Joe Springer
    , contributor
    Comments (2650) | Send Message
    Author’s reply » I think MannKind can make you forget DNDN...two "n's" - LOL!
    27 Feb 2013, 05:40 PM Reply Like
  • sheldond
    , contributor
    Comments (1458) | Send Message
    I don't know technicals other than through Blink type analysis but I like a cup of tea and I love some MNKD. At this point, I don't know what to do. I keep reminding myself to be aware of risk. Do you see shorts daring coming in after these gains?


    I wouldn't but you know them shorts be crazy....always shortin ish


    They are shorts after all its what they do. I have to revisit your first mnkd article and see if anyone was short near 2. That must have hurt. Another reason I never short. Feel good about possible institutional buy ins soon. They always take a few minutes to clear institutional controls and can we get to 5 before May?


    No worries or expectations personally but it does look good and still is building momentum.
    11 Mar 2013, 10:39 PM Reply Like
  • Joe Springer
    , contributor
    Comments (2650) | Send Message
    Author’s reply » In my opinion, there is no way shorts are coming for MannKind again, I think this is the Energizer Bunny.
    12 Mar 2013, 12:42 PM Reply Like
  • pfuchs
    , contributor
    Comments (2) | Send Message
    I would like to hear Joe's take on why Eli Lilly's decision to terminate their Air Insulin drug, citing weak commercial potential was not discussed at all in his extensive and well-balanced analysis.
    12 Mar 2013, 04:09 PM Reply Like
  • sheldond
    , contributor
    Comments (1458) | Send Message


    Joe can you just be direct and stop beating around the bush with your politically correct evasiveness.


    Oops wrong message. Joe can you stop cutting the shorts to pieces with your saber-like tongue.


    I call and they come.


    Interesting action today that was pretty bullish trading action. Not that many weak hands and people still looking to get into mnkd.
    13 Mar 2013, 11:22 PM Reply Like
Full index of posts »
Latest Followers


  • $AMNF $3.8 million cash at end of Q1: Should be able to fund expansion
    May 27, 2016
  • Look $MIK vs other brick&mortars Retail selloff is buy in Amazonprotected MIK 16.3 PE DivCatlyst C
    May 11, 2016
  • $ADMP Adamis License Agreement with Allergan plc Subsidiary for Epinephrine Pre-Filled Syringe Carlo is a dealmaker
    May 10, 2016
More »

Latest Comments

Most Commented
  1. Fire Away ( Comments)
  2. I Am You See ( Comments)
  3. What Is Tonix Worth? ( Comments)
  4. Hooked On Tonix ( Comments)
  5. Seattle Super-Tonix ( Comments)
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.